SEC Form 4 · accession 0001013596-15-000003
Sunshine Biopharma Inc. · SBFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve N. Slilaty
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
May 27, 2015
Accepted (ET)
Jun 1, 2015 · 8:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001402328
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Series "B" Preferred Stock | May 27, 2015 | P | 500,000 | $0.10 | A | 500,000 | D |
Table II — derivative securities
No Table II lines on this filing.